Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure

Pediatric Nephrology

Volumn 21, Issue 6, 2006, Pages 800-806

  Slominska, Ewa M ^a   Kowalik, Katarzyna ^a   Smolenski, Ryszard T ^a   Szolkiewiez, Marek ^a   Rutkowski, Przemyslaw ^a   Rutkowski, Boleslaw ^a   Swierczynski, Julian ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Chronic renal failure; Met2PY; Met4PY; NAD metabolism; Nicotinamide; PARP 1

Indexed keywords

AMIDE; CREATININE; DNA; N METHYL 2 PYRIDONE 5 CARBOXAMIDE; N METHYL 4 PYRIDONE 3 CARBOXAMIDE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; HUMAN; IC 50; IN VITRO STUDY; MALE; METABOLITE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NAD; NIACINAMIDE; POLY(ADP-RIBOSE) POLYMERASES;

EID: 33646701341     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0072-z     Document Type: Article

References (33)

1. Burkle A (2001) Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 23:795-806
2. D'Amours D, Desnoyers S, S'Silva I, Poirier GG (1999) Poly(ADP-ribosyl) reactions in the regulation of nuclear functions. Biochem J 342:249-268
3. Jacobson MK, Jacobson EL (1999) Discovering new ADP-ribose polymer cycles: Protecting the genome and more. Trends Biochem Sci 24:415-417
4. Shibata K, Toda S (1989) Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methyl nicotinamide, N'-methyl-2-pyridone-5-carboxamide and N'-methyl-4-pyridone-3-carboxamide in humans consuming a self-selected food. Am J Clin Nutr 50:114-119
5. Stratford MR, Dennis MF (1992) High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine. J Chromatogr 582:145-151
6. Slominska EM, Smolenski RT, Osborne F, Swierczynski J, Yacoub MH (2005) The effect of N-methyl-2-pyridone-5-carboxamide-a nicotinamide catabolite on poly ADP-rybosylation and oxidative stress injury in endothelial cells. Nucleosides Nucleotides Nucleic Acids 24:259-262
7. Barlow GB, Sutton JL, Wilkinson AW (1977) Metabolism of nicotinic acid in children with burns and scalds. Clin Chim Acta 75:337-342
8. Cazullo CL, Sacchetti E, Smeraldi E (1976) N-Methylnicotinamide excretion and affective disorders. Psychol Med 6:256-270
9. Pumpo R, Sarnelli G, Spinella A, Budillon G, Cuomo R (2001) The metabolism of nicotinamide in human liver cirrhosis: A study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. Am J Gastroenterol 96:1183-1187
10. Aoyama K, Matsubara K, Okada K, Fukushima S, Shimizu K, Yamaguchi S, Uezono T, Satomi M, Hayase N, Ohta S, Shiono H, Kobayashi S (2000) N-Methylation ability for azaheterocyclic amines is higher in Parkinson's disease: Nicotinamide loading test. J Neural Transm 107:985-995
11. Slominska EM, Smolenski RT, Szolkiewicz M, Leaver N, Rutkowski B, Simmonds HA, Swierczynski J (2002) Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Mol Cell Biochem 231:83-88
12. Carrey EA, Smolenski RT, Edbury SM, Laurence A, Marinaki AM, Duley JA, Zhu L, Goldsmith DJ, Simmonds HA (2003) Origin and characteristic of an unusual pyridine nucleotide accumulating in erythrocytes: Positive correlation with degree of renal failure. Clin Chim Acta 335:117-129
13. Vidotto C, Fousert D, Akkerman M, Griesmacher A, Muller MM (2003) Purine and pyrimidine metabolites in children's urine. Clin Chim Acta 335:27-32
14. de Jong JW, Keijzer E, Huizer T, Schoutsen B (1990) Ischemic nucleotide breakdown increases during cardiac development due to drop in adenosine anabolism/catabolism ratio. J Mol Cell Cardiol 22:1065-1070
15. Rutkowski B, Slominska E, Szolkiewicz M, Smolenski RT, Striley C, Rutkowski P, Swierczynski J (2003) N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin? Kidney Int 63(Suppl 84):S19-S21
16. Counahan R, Chantler C, Ghazali S, Kirkwood B, Rose F, Barratt TM (1976) Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 51:875-878
17. Smolenski RT, Lachno DR, Ledingham SJ, Yacoub MH (1990) Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 527:414-420
18. Virag L, Szabo C (2001) Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 15:99-107
19. Okamoto H, Ishikawa A, Yoshitake Y, Kodama N, Nishimuta M, Fukuwatari T, Shibata K (2003) Diurnal variations in human urinary excretion of nicotinamide catabolites: Effects of stress on the metabolism of nicotinamide. Am J Clin Nutr 77:406-410
20. Morena M, Cristol JP, Senecal L, Leray-Moragues H, Krieter D, Canaud B (2002) Oxidative stress in hemodialysis patients: Is NADH oxidase complex the culprit? Kidney Int 61:S109-S114
21. Hasselwander O, Young I (1998) Oxidative stress in chronic renal failure. Free Radic Res 29:1-11
22. Kupper JH, Muller M, Jacobson MK, Tatsumi-Miyajima J, Coyle DL, Jacobson EL, Burkle A (1995) Trans-dominant inhibition of poly(AD-ribosyl)ation sensitizes cells against γ-irradiation and N-methyl-N-nitro-N-nitrosoguanidine but does not limit DNA replication of a polyoma virus replicon. Mol Cell Biol 15:3154-3163
23. Ahnstrom G, Ljungman M (1988) Effects of 3-aminobemzamide on the rejoining of DNA-strand breaks in mammalian cells exposed to methyl methanesulphonate: Role of poly(ADP-ribose) polymerase. Mutat Res 194:17-22
24. Burkle A (2001) Poly(ADP-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett 163:1-5
25. Kurz P, Kohler H, Meuer S, Hutteroth T, Meyer zum Buschenfelde K (1986) Impaired cellular immune response in chronic renal failure: Evidence for a T cell defect. Kidney Int 29:1209-1214
26. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999) Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354:93-99
27. Cochrane CG (1991) Mechanism of oxidant injury of cell. Mol Aspects Med 12:137-147
28. Szabo C, Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19:287-298
29. Ha HC, Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96:13978-13982
30. Martin DR, Lewington AJ, Hammerman MR, Padanilam BJ (2000) Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 279:R1834-R1840
31. Klein HH, Schaper J, Puschmann S, Nienaber C, Kreuzer H, Schaper W (1981) Loss of canine myocardial nicotinamide adenine dinucleotides determines the transition from reversible to irreversible ischemic damage of myocardial cells. Basic Res Cardiol 76:612-621
32. Goodwin POM, Lewis PJ, Davies MI, Skidmore CJ, Shall S (1978) The effect of gamma radiation and neocarzinostatin on NAD and ATP levels in mouse leukemia cells. Biochim Biophys Acta 543:576-582
33. Skidmore CJ, Davies MI, Goodwin PM, Halldorsson H, Lewis PJ, Shall S, Zia'ee AA (1979) The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma radiation and N-methyl-N-nitrosourea. Eur J Biochem 101:135-142